Comparative Assessment of RetCam Effectiveness in the Diagnosis of Small Retinoblastomas in Children
Abstract
Objective. To assess the diagnostic efficacy of the digital retinal camera RetCam compared to traditional ophthalmoscopy in detecting small retinoblastomas (≤3 mm) in children.
Material and methods. The study included 44 children (88 eyes) aged 3 months to 5 years old who were diagnosed with small retinoblastomas. All patients underwent a two-stage ophthalmologic examination using indirect ophthalmoscopy and RetCam. Sensitivity, specificity, and diagnostic accuracy of the methods were evaluated.
Results. The RetCam method demonstrated higher sensitivity (95.5%) and specificity (92.1%) compared to ophthalmoscopy (81.8% and 85.2%, respectively). In 6 cases (13.6%), ophthalmoscopy failed to detect tumors, whereas RetCam successfully identified them. In 4 cases (9.1%), ophthalmoscopy produced false-positive results, which were corrected using RetCam. RetCam also provided detailed visualization of calcifications (18.2%) and hemorrhages (13.6%), allowing for more precise determination of tumor boundaries.
Conclusions. RetCam is a highly effective method for diagnosing small retinoblastomas in children, offering more accurate visualization of tumor foci compared to ophthalmoscopy. The use of RetCam increases the likelihood of early retinoblastoma detection, which plays a key role in treatment strategy selection and disease prognosis.
About the Authors
O. I. Oripov
Ташкентская Медицинская Академия
Russian Federation
Russian Federation
E. N. Bilalov
Ташкентская Медицинская Академия
Russian Federation
Russian Federation
R. Kh. Usmanov
Республиканский специализированный научно-практический медицинский центр онкологии и радиологии
Russian Federation
Russian Federation
O. F. Vokhidov
Ташкентская Медицинская Академия
Russian Federation
Russian Federation
References
1. Abramson D. H., Dunkel I. J., Brodie S. E., Kim J. W., Gobin Y. P. Retinoblastoma in the 21st century. Pediatric Blood & Cancer. 2015; 62(3):345-352. (in Engl) doi:10.1002/pbc.25357.
2. Chantada G., Fandiño A., Manzitti J., Raslawski E., de Dávila M. T. G., Scopinaro M. Retinoblastoma in Latin America: Progress and challenges. Pediatric Blood & Cancer. 2014;61(12):2127-2133. (in Engl) doi:10.1002/pbc.25177.
3. Dimaras H., Kimani K., Dimba E. A., Gronsdahl P., White A., Chan H. S., Gallie B. L. Retinoblastoma. The Lancet. 2012; 379(9824):1436-1446. (in Engl) doi:10.1016/S0140-6736(11)61137-1.
4. Murray T. G., Chantada G., Heon E., Gallie B. L., Singh A. D., Munier F. L., Abramson D. H. [et al.] Global Retinoblastoma Study Group () Global retinoblastoma presentation and analysis by national income level. JAMA Oncology. 2020;6(5):685-695. (in Engl) doi:10.1001/jamaoncol.2019.6716.
5. Gombos D. S., Chevez-Barrios P., Singh A. D., Murray T. G., Hurwitz M. E., Plager D. A., Kychenthal A., Munier F. L. Retinoblastoma in developing countries: The role of RetCam. Journal of Pediatric Ophthalmology & Strabismus. 2016; 53(2):78-85. (in Engl) doi:10.3928/01913913-20160113-01.
6. Munier F. L., Soliman S., Moulin A. P., Gaillard M. C., Balmer A., Beck-Popovic M. Diagnosis of retinoblastoma: The role of RetCam. British Journal of Ophthalmology. 2018;102(6):753-758. (in Engl) doi:10.1136/bjophthalmol-2017-310722.
7. Rodriguez-Galindo C., Wilson M. W., Chantada G. L., Fu L., Qaddoumi I., Luna-Fineman S., O’Brien J. M., Kaste S. C. Retinoblastoma: A global perspective. Pediatric Blood & Cancer. 2017;64(12):E26645. (in Engl) doi:10.1002/pbc.26645.
8. Shields C. L., Kaliki S., Dahmash Al- S., Rojanaporn D., Shukla S. Y., Reilly B., Shields J. A. RetCam imaging of retinoblastoma. Ophthalmology. 2013;120(5):1005-1012. (in Engl) doi:10.1016/j.ophtha.2012.10.016.
9. Soliman S. E., Racher H., Zhang C., MacDonald H., Gallie B. L. Retinoblastoma: A review of the molecular basis of tumor development. Cancers. 2019;11(7):965. (in Engl) doi:10.3390/cancers11070965.
10. Tomar A. S., Finger P. T., Gallie B. L., Kivelä T. T., Khetan V., Mukkamala L. H., Yousef Y. A. Retinoblastoma in India: Clinical presentation and outcomes. Indian Journal of Ophthalmology.2020; 68(5):841-846. (in Engl) doi:10.4103/ijo.IJO_184_20.
11. Yousef Y. A., Soliman S. E., Astudillo P. P., Durairaj P., Dimaras H., Chan H. S., Gallie B. L. RetCam imaging in retinoblastoma: A systematic review. Ophthalmic Genetics. 2015;36(4):307-314. (in Engl) doi:10.3109/13816810.2015.1036591.
12. Zhao J., Li Y., Jin X., Shen L., Chen X., Xu X., Liu Z.Advances in the diagnosis and treatment of retinoblastoma. OncoTargets and Therapy. 2017;10: 3291-3300. (in Engl) doi:10.2147/OTT.S135701.
Review
For citations:
Oripov O.I., Bilalov E.N., Usmanov R.Kh., Vokhidov O.F. Comparative Assessment of RetCam Effectiveness in the Diagnosis of Small Retinoblastomas in Children. Bashkortostan Medical Journal. 2025;20(2):63-66. (In Russ.)
Views:
7
Email this article 
